SCYNEXIS Announces FDA Approval of BREXAFEMME® (ibrexafungerp tablets) as the First and Only Oral Non-Azole Treatment for Vaginal Yeast Infections
Stock Information for SCYNEXIS Inc.
Loading
Please wait while we load your information from QuoteMedia.